Literature DB >> 4624785

Metabolism of T4 bacteriophage ghost-infected cells. II. Do ghosts cause a generalized permeability change?

D H Duckworth, H H Winkler.   

Abstract

Ghosts appear to alter the barrier function of the cell membrane, allowing the release of phosphorylated sugars which normally cannot pass through the cell membrane, whereas phage do not. No increased influx of normally impermeable compounds is observed in the presence of ghosts, indicating that the loss of membrane function after ghost infection cannot be attributed to a generalized breakdown of the permeability barrier.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4624785      PMCID: PMC356396     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Specific inactivation of ribosomes by colicin E3 in vitro and mechanism of immunity in colicinogenic cells.

Authors:  C M Bowman; J Sidikaro; M Nomura
Journal:  Nat New Biol       Date:  1971-12-01

2.  The mode of action of levallorphan as an inhibitor of cell growth.

Authors:  R Greene; B Magasanik
Journal:  Mol Pharmacol       Date:  1967-09       Impact factor: 4.436

3.  Isolation and properties of mutants of Escherichia coli with increased phosphorylations of thiomethyl-beta-galactoside.

Authors:  E R Kashket; T H Wilson
Journal:  Biochim Biophys Acta       Date:  1969

Review 4.  Biological activity of bacteriophage ghosts and "take-over" of host functions by bacteriophage.

Authors:  D H Duckworth
Journal:  Bacteriol Rev       Date:  1970-09

5.  Control of permeation to glycerol in cells of Escherichia coli.

Authors:  Y Sanno; T H Wilson; E C Lin
Journal:  Biochem Biophys Res Commun       Date:  1968-07-26       Impact factor: 3.575

6.  A hexose-phosphate transport system in Escherichia coli.

Authors:  H H Winkler
Journal:  Biochim Biophys Acta       Date:  1966-03-28

7.  A sensitive and convenient micromethod for estimation of urea, citrulline, and carbamyl derivatives.

Authors:  D Hunninghake; S Grisolia
Journal:  Anal Biochem       Date:  1966-08       Impact factor: 3.365

8.  Metabolism of T4 bacteriophage ghost-infected cells: effect of bacteriophage and ghosts on the uptake of carbohydrates in Escherichia coli B.

Authors:  H H Winkler; D H Duckworth
Journal:  J Bacteriol       Date:  1971-07       Impact factor: 3.490

9.  Efflux and the steady state in alpha-methylglucoside transport in Escherichia coli.

Authors:  H H Winkler
Journal:  J Bacteriol       Date:  1971-05       Impact factor: 3.490

10.  Preparation, purification, and properties of E. coli virus T2.

Authors:  R M HERRIOTT; J L BARLOW
Journal:  J Gen Physiol       Date:  1952-05       Impact factor: 4.086

View more
  7 in total

1.  Protein synthesis in bacteriophage ghost-infected cells.

Authors:  K Takeishi; A Kaji
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

Review 2.  Shutoff of host macromolecular synthesis after T-even bacteriophage infection.

Authors:  J F Koerner; D P Snustad
Journal:  Microbiol Rev       Date:  1979-06

Review 3.  Energetics of the first steps of phage infection.

Authors:  B Labedan; L Letellier
Journal:  J Bioenerg Biomembr       Date:  1984-02       Impact factor: 2.945

4.  Isolation and characterization of T-even ghost-tolerant mutants of Escherichia coli.

Authors:  Y Nishikawa; B Maruo
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

5.  Recovery of the accumulation ability of thiomethyl-beta-galactoside in Escherichia coli after bacteriophage T4 infection.

Authors:  N Saijo; K Okamoto
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

6.  Changes in host cell energetics in response to bacteriophage PRD1 DNA entry.

Authors:  R Daugelavicius; J K Bamford; D H Bamford
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

7.  Bacteriophage T4 inhibits colicin E2-induced degradation of Escherichia coli deoxyribonucleic acid. II. Inhibition by T4 ghosts and by T4 in the absence of protein synthesis.

Authors:  R L Swift; J S Wiberg
Journal:  J Virol       Date:  1973-03       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.